2021
DOI: 10.1002/bkcs.12434
|View full text |Cite
|
Sign up to set email alerts
|

Advances in electrochemical aptasensing for cardiac biomarkers

Abstract: Novel bio-receptors or bio-recognition molecular markers with high specificity, stability, and affinity for the efficient binding and entrapment of target biomolecules are essential for developing biomedical devices with high sensitivity and reliability. Aptamers are peptide or nucleic-acid (DNA or RNA) molecules capable of binding to target biomarkers by forming a unique three-dimensional structure, providing an effective platform for biosensing. This review comprehensively summarizes the progress of label-fr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 110 publications
(116 reference statements)
0
3
0
Order By: Relevance
“…Thus, the best solution to control this lethal disease is still isolation of the infected patients through the earlier detection of COVID-19. At present, real-time reverse transcriptionpolymerase chain reaction (RT-PCR) is the ''gold standard" method for diagnosing COVID-Chemosensors 2022, 10, 287 2 of 24 19 disease that is based on the molecular testing of single-strand ribonucleic acid (ssRNA) from the SARS-CoV-2 virus (Figure 1a). Nevertheless, RT-PCR testing is time-consuming, costly, and requires a specialized laboratory setup with expensive instrumentations and trained personnel [7,8].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Thus, the best solution to control this lethal disease is still isolation of the infected patients through the earlier detection of COVID-19. At present, real-time reverse transcriptionpolymerase chain reaction (RT-PCR) is the ''gold standard" method for diagnosing COVID-Chemosensors 2022, 10, 287 2 of 24 19 disease that is based on the molecular testing of single-strand ribonucleic acid (ssRNA) from the SARS-CoV-2 virus (Figure 1a). Nevertheless, RT-PCR testing is time-consuming, costly, and requires a specialized laboratory setup with expensive instrumentations and trained personnel [7,8].…”
Section: Introductionmentioning
confidence: 99%
“…In particular, electrochemistry-based SARS-CoV-2 virus detection systems have received great potential over 'gold standard' RT-PCR, NA amplification assays, and optical methods. This is due to the superior advantages of electrochemical biosensors and immunosensors, including a short reading time, require a small volume of samples, miniaturization ability, point-of-care (POC) and point-of-need (PON) testing, and high sensitivity and specificity [16][17][18][19][20].…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, electroanalytical devices are simple, easy to operate, inexpensive and can be miniaturized for portable use. In biomedical/environmental applications such as point-ofcare testing (POCT) [1][2][3][4][5], pH measurements, and physiological marker identification tests such as for the O 2 and CO 2 content in blood, there is a need for high sensitivity and fast detection of biochemical analytes in small volume samples. Microfluidics can provide additional functionality to electrochemical sensing platforms, enabling them to work with small-volume solutions.…”
mentioning
confidence: 99%